prikaz prve stranice dokumenta Hepatitis C: koga liječiti?
  Download
PDF 81.41 KB
Professional paper - Professional paper
Hepatitis C: koga liječiti?
Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, 67 (2013), 4; 325-327. urn:nbn:hr:184:583641
Štimac, Davor; Bradarić, Nikola; Milić, Sandra

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Štimac, D., Bradarić, N. & Milić, S. (2013). Hepatitis C: koga liječiti?. Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, 67. (4), 325-327. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:583641

Štimac, Davor, et al. "Hepatitis C: koga liječiti?." Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, vol. 67, no. 4, 2013, pp. 325-327. https://urn.nsk.hr/urn:nbn:hr:184:583641

Štimac, Davor, Nikola Bradarić and Sandra Milić. "Hepatitis C: koga liječiti?." Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske 67, no. 4 (2013): 325-327. https://urn.nsk.hr/urn:nbn:hr:184:583641

Štimac, D., Bradarić, N. and Milić, S. (2013) 'Hepatitis C: koga liječiti?', Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, 67(4), pp. 325-327. Available at: https://urn.nsk.hr/urn:nbn:hr:184:583641 (Accessed 13 May 2024)

Štimac D, Bradarić N, Milić S. Hepatitis C: koga liječiti?. Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske [Internet]. 2013 [cited 2024 May 13];67(4):325-327. Available at: https://urn.nsk.hr/urn:nbn:hr:184:583641

D. Štimac, N. Bradarić and S. Milić, "Hepatitis C: koga liječiti?", Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, vol. 67, no. 4, pp. 325-327, 2013. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:583641. [Accessed: 13 May 2024]

Metadata
Title (croatian)Hepatitis C: koga liječiti?
Title (english)HEPATITIS C: WHO SHOULD BE TREATED?
AuthorDavor Štimac
AuthorNikola Bradarić
AuthorSandra Milić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Infectology
Abstract (croatian)
Liječenje je nužno u bolesnika s akutnom infekcijom, bolesnika s povišenim vrijednostima ALT-a, bolesnika s normalnim vrijednostima ALT-a i prisutnom fibrozom od najmanje F2 po METAVIR sustavu ili fibrozom dokazanom nekom neinvazivnom metodom utvrđivanja fibroze, nonrespondera i relapsera genotipa 1 na ranije primijenjenu antivirusnu terapiju (trojna terapija - pegilirani interferon, ribavirin, bocaprevir ili telaprevir), bolesnika s kompenziranom cirozom jetre te bolesnika na hemodijalizi. Liječenje dolazi u obzir u bolesnika s kod koinfekcijom HBV i HIV-om, u bolesnika s teškim ekstrahepatičnim manifestacijama HCV infekcije, u bolesnika ovisnih o teškim drogama i alkoholu nakon najmanje 6 mjeseci apstinencije, moguće i uz suportivnu terapiju metadonom i buprenorfinom, te bolesnika s transplantiranom jetrom. Terapija se ne preporučuje bolesnicima s fulminantnim hepatitisom, bolesnicima s normalnim ALT-om bez prisutne fibroze te bolesnicima s transplantiranim bubregom i trudnicama.
Abstract (english)
Therapy is strongly recommended in patients with acute infection, patients with elevated ALT levels, patients with normal ALT level and F ≥2 METAVIR score, in genotype 1 nonresponders and relapsers to antiviral therapy with triple therapy (pegylated interferon, ribavirin, bocaprevir or telaprevir), in patients with compensated cirrhosis and patients on hemodialysis. It is possible to treat patients with HBV and HIV co-infection, patients with severe HCV extrahepatic manifestations and patients with transplanted liver. Drug users and alcoholics can be treated after 6-month abstinence, but also with supportive therapy. This therapy is not recommended in patients with fulminant hepatitis, patients with persistent normal ALT levels and without fibrosis, in kidney transplant recipients and in pregnant women.
Keywords (croatian)
Keywords (english)
Languagecroatian
Publication typeProfessional paper - Professional paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleActa medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske
Numberingvol. 67, no. 4, pp. 325-327
p-ISSN1330-0164
e-ISSN1848-8897
URN:NBNurn:nbn:hr:184:583641
Publication2013
Document URLhttps://hrcak.srce.hr/113719
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2019-04-08 10:42:58